{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T22:48:15Z","timestamp":1787957295025,"version":"build-2784847793"},"reference-count":63,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["1R01MH123470-01"],"award-info":[{"award-number":["1R01MH123470-01"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","japha.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Pharmacists Association"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.japh.2025.102969","type":"journal-article","created":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T16:36:55Z","timestamp":1762360615000},"page":"102969","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Using implementation science to evaluate perceived feasibility of pharmacy-based HIV services in the Southeastern United States"],"prefix":"10.1016","volume":"66","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-8283-7887","authenticated-orcid":false,"given":"Chante","family":"Hamilton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-1406-3635","authenticated-orcid":false,"given":"Alexis","family":"Hudson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-6880-5405","authenticated-orcid":false,"given":"Samruddhi N.","family":"Borate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6502-2986","authenticated-orcid":false,"given":"Seth","family":"Zissette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Chandra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annabel","family":"Nicholas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry N.","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4859-6304","authenticated-orcid":false,"given":"Natalie D.","family":"Crawford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.japh.2025.102969_bib3","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s11904-019-00447-4","article-title":"Implementation strategies to increase PrEP uptake in the south","volume":"16","author":"Sullivan","year":"2019","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"47","key":"10.1016\/j.japh.2025.102969_bib5","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.15585\/mmwr.mm6647e1","article-title":"Vital signs: human immunodeficiency virus testing and diagnosis delays \u2014 United States","volume":"66","author":"Dailey","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"5","key":"10.1016\/j.japh.2025.102969_bib8","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1331\/JAPhA.2014.14045","article-title":"HIV testing in community pharmacies and retail clinics: a model to expand access to screening for HIV infection","volume":"54","author":"Weidle","year":"2014","journal-title":"J Am Pharm Assoc"},{"issue":"3","key":"10.1016\/j.japh.2025.102969_bib9","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1748-0361.2010.00284.x","article-title":"HIV testing and HIV\/AIDS treatment services in rural Counties in 10 Southern States: service provider perspectives","volume":"26","author":"Sutton","year":"2010","journal-title":"J Rural Health"},{"issue":"4","key":"10.1016\/j.japh.2025.102969_bib10","first-page":"339","article-title":"Missed opportunities for HIV screening in pharmacies and retail clinics","volume":"20","author":"Dugdale","year":"2014","journal-title":"J Manag Care Pharm"},{"issue":"6","key":"10.1016\/j.japh.2025.102969_bib11","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1016\/j.japh.2022.07.003","article-title":"Access to community pharmacies: a nationwide geographic information systems cross-sectional analysis","volume":"62","author":"Berenbrok","year":"2022","journal-title":"J Am Pharm Assoc"},{"issue":"4","key":"10.1016\/j.japh.2025.102969_bib12","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1177\/1715163514535731","article-title":"Patient attitudes regarding the role of the pharmacist and interest in expanded pharmacist services","volume":"147","author":"Kelly","year":"2014","journal-title":"Can Pharm J"},{"issue":"1_suppl","key":"10.1016\/j.japh.2025.102969_bib14","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1177\/00333549161310S116","article-title":"Pharmacy intervention to improve HIV testing uptake using a comprehensive health screening approach","volume":"131","author":"Crawford","year":"2016","journal-title":"Public Health Rep"},{"issue":"6","key":"10.1016\/j.japh.2025.102969_bib15","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1331\/JAPhA.2013.12240","article-title":"Pharmacists' perspectives on HIV testing in community pharmacies","volume":"53","author":"Ryder","year":"2013","journal-title":"J Am Pharm Assoc"},{"issue":"3","key":"10.1016\/j.japh.2025.102969_bib16","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.japh.2022.12.016","article-title":"Influence of patient-pharmacist relationship on willingness to accept pharmacist-provided services","volume":"63","author":"Adekunle","year":"2022","journal-title":"J Am Pharm Assoc"},{"issue":"4","key":"10.1016\/j.japh.2025.102969_bib17","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1331\/JAPhA.2012.10194","article-title":"Pharmacy staff characteristics associated with support for pharmacy-based HIV testing","volume":"52","author":"Amesty","year":"2012","journal-title":"J Am Pharm Assoc"},{"issue":"6","key":"10.1016\/j.japh.2025.102969_bib18","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1007\/s10461-013-0427-y","article-title":"We can do more than just sell the test: pharmacist perspectives about over-the-counter rapid HIV tests","volume":"17","author":"Meyerson","year":"2013","journal-title":"AIDS Behav"},{"issue":"4","key":"10.1016\/j.japh.2025.102969_bib19","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.japh.2019.12.003","article-title":"Pharmacy-based pre-exposure prophylaxis support among pharmacists and men who have sex with men","volume":"60","author":"Crawford","year":"2020","journal-title":"J Am Pharm Assoc"},{"issue":"5","key":"10.1016\/j.japh.2025.102969_bib20","doi-asserted-by":"crossref","DOI":"10.1177\/1524839919857969","article-title":"Pharmacist comfort and awareness of HIV and HCV point-of-care testing in community settings","volume":"21","author":"Min","year":"2019","journal-title":"Health Promot Pract"},{"issue":"2","key":"10.1016\/j.japh.2025.102969_bib21","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3390\/pharmacy9020084","article-title":"Addressing barriers to HIV point-of-care testing in community pharmacies","volume":"9","author":"McKeirnan","year":"2021","journal-title":"Pharmacy"},{"issue":"2","key":"10.1016\/j.japh.2025.102969_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.japh.2024.102291","article-title":"Availability of and attitudes towards harm reduction services: a rural pharmacy perspective","volume":"65","author":"Marley","year":"2024","journal-title":"J Am Pharm Assoc"},{"issue":"5","key":"10.1016\/j.japh.2025.102969_bib23","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.japh.2016.05.004","article-title":"Understanding community pharmacist perceptions and knowledge about HIV preexposure prophylaxis (PrEP) therapy in a Mountain West state","volume":"56","author":"Unni","year":"2016","journal-title":"J Am Pharm Assoc"},{"issue":"11","key":"10.1016\/j.japh.2025.102969_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0207372","article-title":"Midwest pharmacists' familiarity, experience, and willingness to provide pre-exposure prophylaxis (PrEP) for HIV","volume":"13","author":"Broekhuis","year":"2018","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.japh.2025.102969_bib25","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3390\/pharmacy11010009","article-title":"A qualitative systematic literature review of the role of U.S. pharmacists in prescribing pre-exposure prophylaxis (PrEP)","volume":"11","author":"Cernasev","year":"2023","journal-title":"Pharmacy"},{"issue":"7","key":"10.1016\/j.japh.2025.102969_bib26","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1136\/sextrans-2019-054096","article-title":"Pharmacy-based sexual health services: a systematic review of experiences and attitudes of pharmacy users and pharmacy staff","volume":"95","author":"Gauly","year":"2019","journal-title":"Sex Transm Infect"},{"issue":"4","key":"10.1016\/j.japh.2025.102969_bib27","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.japh.2018.04.007","article-title":"HIV pre-exposure prophylaxis: exploring the potential for expanding the role of pharmacists in public health","volume":"58","author":"Okoro","year":"2018","journal-title":"J Am Pharm Assoc"},{"issue":"1","key":"10.1016\/j.japh.2025.102969_bib28","doi-asserted-by":"crossref","DOI":"10.1186\/s12889-024-19836-5","article-title":"Using the andersen healthcare utilization model to assess willingness to screen for prep in pharmacy-based settings among cisgender sexually minoritized men: results from the 2020 American men's internet survey","volume":"24","author":"Alohan","year":"2024","journal-title":"BMC Public Health"},{"issue":"2","key":"10.1016\/j.japh.2025.102969_bib29","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.japh.2022.11.004","article-title":"Examining pharmacies ability to increase pre-exposure prophylaxis (PrEP) access for black men who have sex with men in the United States","volume":"63","author":"Alohan","year":"2022","journal-title":"J Am Pharm Assoc"},{"issue":"4","key":"10.1016\/j.japh.2025.102969_bib30","first-page":"329","article-title":"A survey of South Carolina pharmacists' readiness to prescribe human immunodeficiency virus pre-exposure prophylaxis","volume":"6","author":"Burns","year":"2023","journal-title":"JACCP"},{"issue":"8","key":"10.1016\/j.japh.2025.102969_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0298713","article-title":"Factors influencing the uptake of public health interventions delivery by community pharmacists: a systematic review of global evidence","volume":"19","author":"Mumbi","year":"2024","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.japh.2025.102969_bib32","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofz365","article-title":"Acceptability and feasibility of a pharmacist-led human immunodeficiency virus pre-exposure prophylaxis program in the Midwestern United States","volume":"6","author":"Havens","year":"2019","journal-title":"Open Forum Infect Dis"},{"issue":"1","key":"10.1016\/j.japh.2025.102969_bib33","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13012-023-01286-z","article-title":"Ten years of implementation outcomes research: a scoping review","volume":"18","author":"Proctor","year":"2023","journal-title":"Implement Sci"},{"issue":"1","key":"10.1016\/j.japh.2025.102969_bib34","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s13012-017-0635-3","article-title":"Psychometric assessment of three newly developed implementation outcome measures","volume":"12","author":"Weiner","year":"2017","journal-title":"Implement Sci"},{"issue":"1","key":"10.1016\/j.japh.2025.102969_bib36","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/1748-5908-8-51","article-title":"Evaluation of a large-scale weight management program using the Consolidated Framework for Implementation Research (CFIR)","volume":"8","author":"Damschroder","year":"2013","journal-title":"Implement Sci"},{"issue":"1","key":"10.1016\/j.japh.2025.102969_bib37","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13012-021-01181-5","article-title":"Conceptualizing outcomes for use with the Consolidated Framework for Implementation Research (CFIR): the CFIR outcomes addendum","volume":"17","author":"Damschroder","year":"2022","journal-title":"Implement Sci"},{"issue":"1","key":"10.1016\/j.japh.2025.102969_bib39","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13012-025-01450-7","article-title":"The Consolidated Framework for Implementation Research (CFIR) user guide: a five-step guide for conducting implementation research using the framework","volume":"20","author":"Reardon","year":"2025","journal-title":"Implement Sci"},{"key":"10.1016\/j.japh.2025.102969_bib40","doi-asserted-by":"crossref","DOI":"10.3389\/frph.2023.1023568","article-title":"Barriers to and strategies for early implementation of pharmacy-delivered HIV PrEP services in Kenya: an analysis of routine data","volume":"5","author":"Nakambale","year":"2023","journal-title":"Front Reprod Health"},{"issue":"S3","key":"10.1016\/j.japh.2025.102969_bib41","doi-asserted-by":"crossref","DOI":"10.1002\/jia2.26442","article-title":"High acceptability, feasibility and sustainability of a direct-to-pharmacy differentiated PrEP delivery model in public health HIV clinics in Kenya: perspectives of PrEP clients and healthcare providers","volume":"28","author":"Owidi","year":"2025","journal-title":"J Int AIDS Soc"},{"issue":"1","key":"10.1016\/j.japh.2025.102969_bib42","doi-asserted-by":"crossref","DOI":"10.1186\/s12913-025-12971-8","article-title":"Preparing for pharmacy-based delivery of long-acting injectable antiretrovirals: a pre-implementation study","volume":"25","author":"Cocohoba","year":"2025","journal-title":"BMC Health Serv Res"},{"issue":"1","key":"10.1016\/j.japh.2025.102969_bib43","doi-asserted-by":"crossref","DOI":"10.1186\/s12913-023-10277-1","article-title":"Addressing disparities in Pre-Exposure Prophylaxis (PrEP) access: implementing a community-centered mobile PrEP program in South Florida","volume":"23","author":"Butts","year":"2023","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.japh.2025.102969_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2022.103924","article-title":"Barriers and facilitators to implementing a pharmacist, physician, and Patient Navigator-Collaborative Care Model (PPP-CCM) to treat hepatitis C among people who inject drugs","volume":"111","author":"Austin","year":"2023","journal-title":"Int J Drug Policy"},{"key":"10.1016\/j.japh.2025.102969_bib45","article-title":"Exploring facilitators and barriers to early TB case finding at private community pharmacies in Kampala, Uganda using the Consolidated Framework for Implementation Research (CFIR)","author":"Rodgers","year":"2025","journal-title":"Res Sq"},{"issue":"1","key":"10.1016\/j.japh.2025.102969_bib46","doi-asserted-by":"crossref","DOI":"10.1080\/16549716.2021.1979281","article-title":"Factors associated with low tuberculosis preventive therapy prescription rates among health care workers in rural South Africa","volume":"14","author":"Ahmed","year":"2021","journal-title":"Glob Health Action"},{"issue":"4","key":"10.1016\/j.japh.2025.102969_bib47","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgph.0004006","article-title":"Barriers and facilitators to oral pre-exposure prophylaxis uptake among adolescents girls and young women at elevated risk of HIV acquisition in Lilongwe, Malawi: a qualitative study","volume":"5","author":"Nicholas","year":"2025","journal-title":"PLOS Glob Public Health"},{"issue":"5","key":"10.1016\/j.japh.2025.102969_bib48","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.sapharm.2017.06.001","article-title":"Application of the Consolidated Framework for Implementation Research to community pharmacy: a framework for implementation research on pharmacy services","volume":"13","author":"Shoemaker","year":"2017","journal-title":"Res Social Adm Pharm"},{"issue":"10","key":"10.1016\/j.japh.2025.102969_bib49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0311694","article-title":"Development of a pharmacy-based HIV PrEP service delivery intervention for Washington, District of Columbia (DC): a study protocol","volume":"19","author":"Tun","year":"2024","journal-title":"PLoS ONE"},{"key":"10.1016\/j.japh.2025.102969_bib50","doi-asserted-by":"crossref","DOI":"10.2196\/72283","article-title":"Improving access to HIV prevention services in community pharmacies in the US Southeast: protocol for a hybrid type 1 effectiveness-implementation study","author":"Alohan","year":"2025","journal-title":"JMIR Res Protoc"},{"issue":"2","key":"10.1016\/j.japh.2025.102969_bib51","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1521\/aeap.14.2.172.23902","article-title":"Development and psychometric evaluation of the brief HIV Knowledge questionnaire","volume":"14","author":"Carey","year":"2002","journal-title":"AIDS Educ Prev"},{"issue":"7","key":"10.1016\/j.japh.2025.102969_bib53","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1093\/aje\/kwh090","article-title":"A modified poisson regression approach to prospective studies with binary data","volume":"159","author":"Zou","year":"2004","journal-title":"Am J Epidemiol"},{"issue":"1","key":"10.1016\/j.japh.2025.102969_bib54","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1471-2288-3-21","article-title":"Alternatives for logistic regression in cross-sectional studies: an empirical comparison of models that directly estimate the prevalence ratio","volume":"3","author":"Barros","year":"2003","journal-title":"BMC Med Res Methodol"},{"issue":"2","key":"10.1016\/j.japh.2025.102969_bib55","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.jcm.2016.02.012","article-title":"A guideline of selecting and reporting intraclass correlation coefficients for reliability research","volume":"15","author":"Koo","year":"2016","journal-title":"J Chiropr Med"},{"issue":"2","key":"10.1016\/j.japh.2025.102969_bib56","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/01.PHH.0000311888.06252.bb","article-title":"A glossary for dissemination and implementation research in health","volume":"14","author":"Rabin","year":"2008","journal-title":"J Public Health Manag Pract"},{"issue":"3-4","key":"10.1016\/j.japh.2025.102969_bib57","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1503\/cmaj.081229","article-title":"Defining knowledge translation","volume":"181","author":"Straus","year":"2009","journal-title":"Can Med Assoc J"},{"issue":"1","key":"10.1016\/j.japh.2025.102969_bib58","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13012-022-01201-y","article-title":"Revisiting concepts of evidence in implementation science","volume":"17","author":"Brownson","year":"2022","journal-title":"Implemen Sci"},{"issue":"S6","key":"10.1016\/j.japh.2025.102969_bib59","doi-asserted-by":"crossref","DOI":"10.1002\/jia2.25350","article-title":"Community engagement in the provision of culturally competent HIV and STI prevention services: lessons from the French experience in the era of Pr EP","volume":"22","author":"Rojas Castro","year":"2019","journal-title":"J Int AIDS Soc"},{"issue":"11S","key":"10.1016\/j.japh.2025.102969_bib61","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1097\/OLQ.0000000000001643","article-title":"Examining the multilevel barriers to pharmacy-based HIV prevention and treatment services","volume":"49","author":"Crawford","year":"2022","journal-title":"Sex Transm Dis"},{"issue":"5","key":"10.1016\/j.japh.2025.102969_bib62","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1007\/s10461-021-03494-4","article-title":"Pharmacy-based interventions to increase use of HIV pre-exposure prophylaxis in the United States: a scoping review","volume":"26","author":"Zhao","year":"2021","journal-title":"AIDS Behav"},{"issue":"7","key":"10.1016\/j.japh.2025.102969_bib63","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-047034","article-title":"Sexual and reproductive health services provided by community pharmacists: a scoping review","volume":"11","author":"Navarrete","year":"2021","journal-title":"BMJ Open"},{"issue":"4","key":"10.1016\/j.japh.2025.102969_bib64","doi-asserted-by":"crossref","first-page":"S30","DOI":"10.1016\/j.japh.2021.06.001","article-title":"Impact of pharmacist-led program on knowledge of college students about pre-exposure prophylaxis","volume":"61","author":"Taliaferro","year":"2021","journal-title":"J Am Pharm Assoc"},{"issue":"1","key":"10.1016\/j.japh.2025.102969_bib65","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1186\/s12889-023-16072-1","article-title":"Persistence in a pharmacist-led, same-day PrEP program in Mississippi: a mixed-methods study","volume":"23","author":"Khosropour","year":"2023","journal-title":"BMC Public Health"},{"issue":"6","key":"10.1016\/j.japh.2025.102969_bib66","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1097\/JNC.0000000000000182","article-title":"Integrated pharmacy and PrEP navigation services to support PrEP uptake: a quality improvement project","volume":"31","author":"Coleman","year":"2020","journal-title":"J Assoc Nurses AIDS Care"},{"issue":"11","key":"10.1016\/j.japh.2025.102969_bib67","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofad549","article-title":"Opportunities to increase access to HIV prevention: evaluating the implementation of pharmacist-initiated pre-exposure prophylaxis in California","volume":"10","author":"Hunter","year":"2023","journal-title":"Open Forum Infect Dis"},{"issue":"6","key":"10.1016\/j.japh.2025.102969_bib68","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1331\/JAPhA.2011.10190","article-title":"Pharmacists' strategies for promoting medication adherence among patients with HIV","volume":"51","author":"Kibicho","year":"2011","journal-title":"J Am Pharm Assoc"},{"issue":"2","key":"10.1016\/j.japh.2025.102969_bib69","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1007\/s11524-011-9651-9","article-title":"Injection drug users' perspectives on placing HIV prevention and other clinical services in pharmacy settings","volume":"89","author":"Lutnick","year":"2012","journal-title":"J Urban Health"},{"issue":"3","key":"10.1016\/j.japh.2025.102969_bib70","doi-asserted-by":"crossref","first-page":"256","DOI":"10.2105\/AJPH.2022.307190","article-title":"The future of pharmacist-delivered status-neutral HIV prevention and care","volume":"113","author":"Weidle","year":"2023","journal-title":"Am J Public Health"},{"issue":"1","key":"10.1016\/j.japh.2025.102969_bib71","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/sj.ebd.6400375","article-title":"Study design III: cross-sectional studies","volume":"7","author":"Levin","year":"2006","journal-title":"Evid Based Dent"},{"key":"10.1016\/j.japh.2025.102969_bib72","author":"Rothman"},{"key":"10.1016\/j.japh.2025.102969_bib73","author":"Van de Mortel"}],"container-title":["Journal of the American Pharmacists Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S154431912500648X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S154431912500648X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T12:15:38Z","timestamp":1773836138000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S154431912500648X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":63,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S154431912500648X"],"URL":"https:\/\/doi.org\/10.1016\/j.japh.2025.102969","relation":{},"ISSN":["1544-3191"],"issn-type":[{"value":"1544-3191","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Using implementation science to evaluate perceived feasibility of pharmacy-based HIV services in the Southeastern United States","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Pharmacists Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.japh.2025.102969","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Inc. on behalf of the American Pharmacists Association.","name":"copyright","label":"Copyright"}],"article-number":"102969"}}